Burden of Rotavirus Disease in Norway

Tone Bruun(Oslo University Hospital), Beatriz Valcárcel Salamanca(Norwegian University of Science and Technology), Terese Bekkevold(Stavanger University Hospital), Kirsti Vainio(Oslo University Hospital), Moustafa Gibory(Østfold Hospital Trust), Kirsti Egge Haugstad(St Olav's University Hospital), A Rojahn(Stavanger University Hospital), Kirsti Jakobsen(Norwegian University of Science and Technology), Gunnar Størvold(Norwegian University of Science and Technology), Anette Lunde(Norwegian University of Science and Technology), Ketil Størdal(Norwegian Institute of Public Health), Anita Kanestrøm(Østfold Hospital Trust), Magnhild Owesen Eidem(Oslo University Hospital), Henrik Døllner(Oslo University Hospital), Lars Høsøien Skanke(Østfold Hospital Trust), Svein Arne Nordbø(Stavanger University Hospital), Heidi Sivertsen(Norwegian University of Science and Technology), Ann Marit Gilje(Norwegian Institute of Public Health), Elisebet Haarr(Stavanger University Hospital), Elmira Flem(Oslo University Hospital)
The Pediatric Infectious Disease Journal
January 8, 2016
Cited by 18Open Access
Full Text

Abstract

BACKGROUND: Norway introduced routine rotavirus immunization for all children born on or after September 1, 2014. We estimated the healthcare burden of all-cause gastroenteritis and rotavirus disease in children <5 years old to establish the prevaccine baseline and support the ongoing immunization program. METHODS: We examined national registry data on gastroenteritis-associated primary care consultations and hospitalizations for 2009-2013 and data on all deaths in children <5 years old reported during 2000-2013. We also established rotavirus hospital surveillance from February 2014 through January 2015. RESULTS: Before vaccine introduction, 114.5 cases per 1000 children <5 years old were treated in primary care and 11.8 children per 1000 were hospitalized with gastroenteritis annually. During hospital surveillance, rotavirus was detected in 65% (95% confidence interval: 60-70) of inpatient gastroenteritis cases. We estimated that 4.0 inpatient and 2.3 outpatient cases per 1000 children were seen in hospital with rotavirus disease annually, suggesting that 1 in 32 children was hospitalized by age 5. Additional 30.6 rotavirus cases per 1000 children consulted primary care annually or 1 in every 7 children by the age of 5 years. Rotavirus-associated mortality was estimated at 0.17 deaths per 100,000 children <5 years old, corresponding to 1 death every second year. CONCLUSIONS: Rotavirus remains the primary cause of severe gastroenteritis in children in Norway. The unique population-based registers, in combination with an established rotavirus surveillance platform, provide a well-suited setting to evaluate the impact of rotavirus vaccination.


Related Papers

No related papers found

Powered by citation graph analysis